Previous clients
Leading Diagnostics Companies
Alere Inc (Abbott Laboratories), Waltham, MA, USA
Agilent Technologies Inc, Santa Clara, CA, USA
Becton Dickinson and Company, Franklin Lakes, NJ, USA
Bio-Rad Laboratories, Hercules, CA, USA
Johnson & Johnson, USA
Millipore Sigma, St Louis, MO, USA
Roche Diagnostics, Global Business Development, Pleasanton, CA, USA
Roche Sequencing Solutions, Pleasanton, CA, USA
SeeGene Inc., Walnut Creek, CA, USA
Thermo Fisher Scientific, Waltham, MA, USA
Early Stage Diagnostics Innovators:
DirectBio, San Francisco, CA, USA
DeBiopharm Group, Lausanne, Switzerland
GenePOC Inc., Quebec, Canada
InstaDiagnostics, Philadelphia, PA, USA
Lophius Biosciences GmbH, Regensburg, Germany
LuminUltra Technologies Ltd, Fredericton, Canada
MOBILion Systems, Chadds Ford, PA, USA
ODx Innovations, Inverness, Scotland, UK
Prolocor Inc., Philadelphia, PA, USA
Qurasense Inc., Menlo Park, CA, USA
SciLogica Ltd, Abingdon, Oxfordshire, UK
Sense Biodetection Ltd, Oxford, UK
Singulex Inc., Alameda, CA, USA
STAT-Diagnostica and Innovation S.L, Barcelona, Spain
Wako Diagnostics, Moutainview, CA, USA
NGOs & Foundations
FIND, Geneva, Switzerland
LifeArc, UK
World Health Organisation, Geneva, Switzerland
Consulting Companies & Publications
IVD Logix LLC, Dallas, TX, USA (IVD Market Research)
Market Diagnostics International LLC, Dallas, TX, USA (US IVD User Data)
Precision for Medicine Group, Inc., Frederick, MD, USA (Regulatory Support)
The MedTech Strategist, USA
Speaking Engagements:
Cambridge HealthTech Next Generation Dx Summit (Washington DC, August 2024)
Title: Applying Current Oncology Screening Technologies in Low- and Middle-Income Countries
Cambridge HealthTech Next Generation Dx Summit (Washington DC, August 2023)
Title: Meeting the Needs for POCT in the World’s Low-and-Middle IncomeCountries
Molecular Medicine Triconference (San Francisco, March 2020)
Title: How Infectious Disease Molecular Multiplexing is Shaping Up (Part I): Market Environment and Competitive Landscape
Cambridge HealthTech Next Generation Dx Summit (Washington DC, August 2019)
Title: Trends and Countertrends in Point of Care Testing
DxMA Seminar at the Association of Molecular Pathologists (AMP) conference (November 2016)
Title: Counter Trends in Global Infectious Disease Testing: To Decentralise Molecular Testing or Not